Impact of the use of aminoglycosides in combination antibiotic therapy on septic shock and mortality due to Staphylococcus aureus bacteremia

European Journal of Internal Medicine

Volumn 17, Issue 4, 2006, Pages 276-280

  Lesens, O ^a   Brannigan, E ^b   Bergin, C ^b   Christmann, D ^c   Hansmann, Y ^c  

^a HÔTEL DIEU   (France)

^b ST JAMES S HOSPITAL   (Ireland)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Aminoglycoside; Bacteremia; Staphylococcus aureus

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; GENTAMICIN;

ADULT; AGED; ARTICLE; BACTEREMIA; BLOOD CULTURE; CATHETER INFECTION; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; FEMALE; FRANCE; HAZARD ASSESSMENT; HUMAN; IRELAND; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; TERTIARY HEALTH CARE; UNIVARIATE ANALYSIS;

EID: 33744508613     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2005.12.004     Document Type: Article

References (21)

1. Weinstein M.P., Towns M.L., Quartey S.M., Mirrett S., Reimer L.G., Parmigiani G., et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 24 (1997) 584-602
2. Fowler Jr. V.G., Sanders L.L., Sexton D.J., Kong L., Marr K.A., Gopal A.K., et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 27 (1998) 478-486
3. Mylotte J.M., McDermott C., and Spooner J.A. Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Rev Infect Dis 9 (1987) 891-907
4. Romero-Vivas J., Rubio M., Fernandez C., and Picazo J.J. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 21 6 (1995 (Dec)) 1417-1423
5. Soriano A., Martinez J.A., Mensa J., Marco F., Almela M., Moreno-Martinez A., et al. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis 30 2 (2000 (Feb)) 368-373
6. Jensen A.G., Wachmann C.H., Espersen F., Scheibel J., Skinhoj P., and Frimodt-Moller N. Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases. Arch Intern Med 162 1 (2002 (Jan 14)) 25-32
7. McClelland R.S., Fowler V.G., Sanders L.L., Gottlieb G., Kong L.K., Sexton D.J., et al. Staphylococcus aureus bacteremia among elderly vs younger adult patients: comparison of clinical features and mortality. Arch Intern Med 159 (1999) 1244-1247
8. Jensen A.G., et al. Risk factors for hospital-acquired Staphylococcus bacteremia. Arch Intern Med 159 (1999) 1437-1444
9. Chang F.Y., Peacock Jr. J.E., Musher D.M., Triplett P., MacDonald B.B., Mylotte J.M., et al. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore) 82 5 (2003 (Sep)) 333-339
10. Lesens O., Methlin C., Hansmann Y., Remy V., Martinot M., Bergin C., et al. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity. Infect Control Hosp Epidemiol 24 12 (2003 (Dec)) 890-896
11. Lesens O., Hansmann Y., Brannigan E., Remy V., Hopkins S., Martinot M., et al. Positive surveillance blood culture is a predictive factor for secondary metastatic infection in patients with Staphylococcus aureus bacteraemia. J Infect 48 3 (2004 (Apr)) 245-252
12. Le T., and Bayer A.S. Combination antibiotic therapy for infective endocarditis. Clin Infect Dis 36 5 (2003 (Mar 1)) 615-621
13. Moellering R.C. Principles of anti-infective therapy. In: Mandel G.L., Bennett J.E., and Dolin R. (Eds). Mandell, Douglas and Bennett's Principles and practices of infectious diseases. 4th ed. (1995), Churchill Livingstone, New York, NY 207
14. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 5 (1987) 373-383
15. Sekeres M.A., Abrutyn E., Berlin J.A., et al. An assessment of the usefulness of the Duke criteria for diagnosing active infective endocarditis. Clin Infect Dis 24 (1997) 1185-1190
16. Cosgrove S.E., and Carmeli Y. Studies of bloodstream infection outcomes: reading between the lines. Infect Control Hosp Epidemiol 24 12 (2003 (Dec)) 884-886
17. Fantin B., and Carbon C. In vivo antibiotic synergism: contribution of animal models. Antimicrob Agents Chemother 36 5 (1992 (May)) 907-912
18. Goldstein F.W., et al. Vancomycin-Aminoglycosides: An Inappropriate Combination for the Treatment of GISA and other MRSA Infections, Rochon-Edouard (2000)
19. Ida T., Okamoto R., Nonoyama M., Irinoda K., Kurazono M., and Inoue M. Antagonism between aminoglycosides and beta-lactams in a methicillin-resistant Staphylococcus aureus isolate involves induction of an aminoglycoside-modifying enzyme. Antimicrob Agents Chemother 46 5 (2002 (May)) 1516-1521
20. Ervin F.R., Bullock Jr. E.E., and Nuttall C.E. Inactivation of gentamicin by penicillins in patients with renal failure. Antimicrob Agents Chemother 9 6 (1976 (Jun)) 1004-1011
21. Le T., and Bayer A.S. Combination antibiotic therapy for infective endocarditis. Clin Infect Dis 36 5 (2003 (Mar 1)) 615-621 [Epub 2003 Feb 13]